Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based study
<p>Abstract</p> <p>Background</p> <p>Estimating the seroprevalence of HIV in a low risk population such as pregnant women provides essential information for an effective implementation of AIDS control programmes, and also for the monitoring of HIV spread within a countr...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2007-11-01
|
| Series: | BMC Infectious Diseases |
| Online Access: | http://www.biomedcentral.com/1471-2334/7/133 |
| _version_ | 1818445166433796096 |
|---|---|
| author | Singh Sarman Gupta Richa Gupta Swati |
| author_facet | Singh Sarman Gupta Richa Gupta Swati |
| author_sort | Singh Sarman |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Estimating the seroprevalence of HIV in a low risk population such as pregnant women provides essential information for an effective implementation of AIDS control programmes, and also for the monitoring of HIV spread within a country. Very few studies are available from north India showing the current trend in HIV prevalence in the antenatal population;which led us to carry outthis study at a tertiary care hospital in north India</p> <p>Methods</p> <p>Blood samples from pregnant women attending antenatal clinics at the All India Institute of Medical Sciences, New Delhi were collected after informed consent and pre-test counseling. The samples were tested for HIV antibodies as per the WHO guidelines, over a period of four years from January 2003 to December 2006.</p> <p>Results</p> <p>Of the 3529 pregnant women tested in four years, 0.88% (CI 0.5 – 1.24) women were found to be HIV seroreactive. Majority of the seroreactive pregnant women (41.9%) were in the age group of 20–24 years followed by the 30–34 yrs (25.8%) and 25–29 years (22.6%) age group. The mean age of the HIV positive women was 24.9 years (SD ± 1.49 yrs). The HIV seroprevalence rates showed an increasing trend from 0.7% (CI 0.14 – 2.04) in 2003–2004 to 0.9% (CI 0.49 – 1.5) in 2005–2006. This prevalence rate indicates concern, as Delhi and its adjoining states are otherwise considered as 'low prevalence states'.</p> <p>Conclusion</p> <p>Seroprevalence of HIV infection was found to be increasing in the last four years amongst pregnant women of North India. These findings are in contrast to the national projections.</p> |
| first_indexed | 2024-12-14T19:27:31Z |
| format | Article |
| id | doaj.art-7da42ad718c34fa196fad1cefb1b5b1a |
| institution | Directory Open Access Journal |
| issn | 1471-2334 |
| language | English |
| last_indexed | 2024-12-14T19:27:31Z |
| publishDate | 2007-11-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Infectious Diseases |
| spelling | doaj.art-7da42ad718c34fa196fad1cefb1b5b1a2022-12-21T22:50:10ZengBMCBMC Infectious Diseases1471-23342007-11-017113310.1186/1471-2334-7-133Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based studySingh SarmanGupta RichaGupta Swati<p>Abstract</p> <p>Background</p> <p>Estimating the seroprevalence of HIV in a low risk population such as pregnant women provides essential information for an effective implementation of AIDS control programmes, and also for the monitoring of HIV spread within a country. Very few studies are available from north India showing the current trend in HIV prevalence in the antenatal population;which led us to carry outthis study at a tertiary care hospital in north India</p> <p>Methods</p> <p>Blood samples from pregnant women attending antenatal clinics at the All India Institute of Medical Sciences, New Delhi were collected after informed consent and pre-test counseling. The samples were tested for HIV antibodies as per the WHO guidelines, over a period of four years from January 2003 to December 2006.</p> <p>Results</p> <p>Of the 3529 pregnant women tested in four years, 0.88% (CI 0.5 – 1.24) women were found to be HIV seroreactive. Majority of the seroreactive pregnant women (41.9%) were in the age group of 20–24 years followed by the 30–34 yrs (25.8%) and 25–29 years (22.6%) age group. The mean age of the HIV positive women was 24.9 years (SD ± 1.49 yrs). The HIV seroprevalence rates showed an increasing trend from 0.7% (CI 0.14 – 2.04) in 2003–2004 to 0.9% (CI 0.49 – 1.5) in 2005–2006. This prevalence rate indicates concern, as Delhi and its adjoining states are otherwise considered as 'low prevalence states'.</p> <p>Conclusion</p> <p>Seroprevalence of HIV infection was found to be increasing in the last four years amongst pregnant women of North India. These findings are in contrast to the national projections.</p>http://www.biomedcentral.com/1471-2334/7/133 |
| spellingShingle | Singh Sarman Gupta Richa Gupta Swati Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based study BMC Infectious Diseases |
| title | Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based study |
| title_full | Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based study |
| title_fullStr | Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based study |
| title_full_unstemmed | Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based study |
| title_short | Seroprevalence of HIV in pregnant women in North India: a tertiary care hospital based study |
| title_sort | seroprevalence of hiv in pregnant women in north india a tertiary care hospital based study |
| url | http://www.biomedcentral.com/1471-2334/7/133 |
| work_keys_str_mv | AT singhsarman seroprevalenceofhivinpregnantwomeninnorthindiaatertiarycarehospitalbasedstudy AT guptaricha seroprevalenceofhivinpregnantwomeninnorthindiaatertiarycarehospitalbasedstudy AT guptaswati seroprevalenceofhivinpregnantwomeninnorthindiaatertiarycarehospitalbasedstudy |